Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Tumor volume reduction assessed by planning computed tomography in patients with rectal cancer during preoperative chemoradiation: impact of residual tumor volume on the prediction of pathologic tumor regression.

Lee JA, Yang D, Yoon WS, Park YJ, Kim CY, Moon HY, Lee SI.

Tumori. 2014 Mar-Apr;100(2):158-62. doi: 10.1700/1491.16401.

PMID:
24852859
[PubMed - indexed for MEDLINE]
2.

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.

Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM.

Cancer. 2013 Dec 15;119(24):4231-41. doi: 10.1002/cncr.28331. Epub 2013 Oct 1.

PMID:
24089344
[PubMed - indexed for MEDLINE]
3.

Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer.

Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D'Amico R, Conte PF, Natalini G.

Dis Colon Rectum. 2005 Oct;48(10):1851-7.

PMID:
16132481
[PubMed - indexed for MEDLINE]
4.

Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.

Duldulao MP, Lee W, Streja L, Chu P, Li W, Chen Z, Kim J, Garcia-Aguilar J.

Dis Colon Rectum. 2013 Feb;56(2):142-9. doi: 10.1097/DCR.0b013e31827541e2.

PMID:
23303141
[PubMed - indexed for MEDLINE]
5.

Computed tomography with histological correlation for evaluating tumor regression of rectal carcinoma after preoperative chemoradiation therapy.

Lee CT, Chow NH, Liu YS, Lin SC, Lin PC, Wu YH, Lee JC, Tsai HM.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2484-9.

PMID:
22497951
[PubMed - indexed for MEDLINE]
6.

Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor.

Passoni P, Fiorino C, Slim N, Ronzoni M, Ricci V, Di Palo S, De Nardi P, Orsenigo E, Tamburini A, De Cobelli F, Losio C, Iacovelli NA, Broggi S, Staudacher C, Calandrino R, Di Muzio N.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):67-72. doi: 10.1016/j.ijrobp.2013.05.004. Epub 2013 Jun 19.

PMID:
23790770
[PubMed - indexed for MEDLINE]
7.

CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.

Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.

Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

PMID:
23739192
[PubMed - indexed for MEDLINE]
8.

The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.

Roy P, Serra S, Kennedy E, Chetty R.

J Surg Oncol. 2012 Feb;105(2):130-4. doi: 10.1002/jso.22073. Epub 2011 Aug 12.

PMID:
21842520
[PubMed - indexed for MEDLINE]
9.

Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.

Yeo SG, Kim DY, Kim TH, Jung KH, Hong YS, Chang HJ, Park JW, Lim SB, Choi HS, Jeong SY.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):164-71. doi: 10.1016/j.ijrobp.2009.07.1682. Epub 2009 Dec 11.

PMID:
20004532
[PubMed - indexed for MEDLINE]
10.

Pilot study of intense neoadjuvant chemoradiotherapy for locally advanced rectal cancer: retrospective review of a phase II study.

Xu BH, Chi P, Guo JH, Guan GX, Tang TL, Yang YH, Chen MQ, Song JY, Feng CY.

Tumori. 2014 Mar-Apr;100(2):149-57. doi: 10.1700/1491.16399.

PMID:
24852858
[PubMed - indexed for MEDLINE]
11.

Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.

Mace AG, Gantt GA, Skacel M, Pai R, Hammel JP, Kalady MF.

Dis Colon Rectum. 2013 Nov;56(11):1217-27. doi: 10.1097/DCR.0b013e3182a4b236.

PMID:
24104995
[PubMed - indexed for MEDLINE]
12.

The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.

Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.

Am J Clin Oncol. 2012 Aug;35(4):340-4. doi: 10.1097/COC.0b013e3182118e7d.

PMID:
21422901
[PubMed - indexed for MEDLINE]
13.

Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.

Oberholzer K, Menig M, Kreft A, Schneider A, Junginger T, Heintz A, Kreitner KF, Hötker AM, Hansen T, Düber C, Schmidberger H.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):842-8. doi: 10.1016/j.ijrobp.2010.08.057. Epub 2011 Jan 13.

PMID:
21236593
[PubMed - indexed for MEDLINE]
14.

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.

Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.

Dis Colon Rectum. 2004 Dec;47(12):2025-31.

PMID:
15657650
[PubMed - indexed for MEDLINE]
15.

Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.

Shia J, McManus M, Guillem JG, Leibold T, Zhou Q, Tang LH, Riedel ER, Weiser MR, Paty PB, Temple LK, Nash G, Kolosov K, Minsky BD, Wong WD, Klimstra DS.

Am J Surg Pathol. 2011 Jan;35(1):127-34. doi: 10.1097/PAS.0b013e318200cf78.

PMID:
21164296
[PubMed - indexed for MEDLINE]
16.

Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.

Vironen J, Juhola M, Kairaluoma M, Jantunen I, Kellokumpu I.

Int J Colorectal Dis. 2005 Sep;20(5):440-5. Epub 2005 Apr 23.

PMID:
15856263
[PubMed - indexed for MEDLINE]
17.

Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT.

Am J Clin Oncol. 2012 Aug;35(4):334-9. doi: 10.1097/COC.0b013e3182118d12.

PMID:
21422989
[PubMed - indexed for MEDLINE]
18.

Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?

Park SY, Chang HJ, Kim DY, Jung KH, Kim SY, Park JW, Oh JH, Lim SB, Choi HS, Jeong SY.

Histopathology. 2011 Oct;59(4):650-9. doi: 10.1111/j.1365-2559.2011.03980.x.

PMID:
22014046
[PubMed - indexed for MEDLINE]
19.

Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).

Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Julião GP, Lynn P, Ono CR, Campos FG, Silva e Sousa AH Jr, Imperiale AR, Nahas SC, Buchpiguel CA.

Cancer. 2012 Jul 15;118(14):3501-11. doi: 10.1002/cncr.26644. Epub 2011 Nov 15.

PMID:
22086847
[PubMed - indexed for MEDLINE]
Free Article
20.

A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.

Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.

Ann Surg Oncol. 2008 Dec;15(12):3471-7. doi: 10.1245/s10434-008-0149-y. Epub 2008 Oct 10.

PMID:
18846402
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk